Lincoln Pharmaceuticals Limited

NSE LINCOLN.NS

Lincoln Pharmaceuticals Limited Dividend Yield on February 06, 2025: 0.21%

Lincoln Pharmaceuticals Limited Dividend Yield is 0.21% on February 06, 2025, a -7.39% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Lincoln Pharmaceuticals Limited 52-week high Dividend Yield is 0.28% on June 04, 2024, which is 31.46% above the current Dividend Yield.
Lincoln Pharmaceuticals Limited 52-week low Dividend Yield is 0.16% on December 10, 2024, which is -25.35% below the current Dividend Yield.
Lincoln Pharmaceuticals Limited average Dividend Yield for the last 52 weeks is 0.23%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

NSE: LINCOLN.NS

Lincoln Pharmaceuticals Limited

CEO	Mr. Mahendrabhai Gulabdas Patel B.A, LLB
IPO Date	Dec. 17, 2015
Location	India
Headquarters	Lincoln House
Employees	1,687
Sector	Healthcare
Industries Pharmaceuticals Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Eyewear Personal Care

Description

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative. The company also offers branded generics. Lincoln Pharmaceuticals Limited was founded in 1979 and is based in Ahmedabad, India.

Key trends

Past 5 years